Couple of things.
About the share price, it has no business being this low, not with the collaborations that Bioasis has going on. I don't think there's enough BTI volume to consider there to be a shareholder capitulation going on.
We could be seeing some malicious selling. There are shareholders whose methods of expressing anxiety and disappointment are to try to cause damage to the company and its shareholders. That's how trolls operate. Selling some shares to drive the share price down when the opportunity is presented can be an extension of troll-like behaviour.
If somebody is trying to set a low price for a financing then Bioasis may be able to exercise the Lind Partners funding agreement to get some operational runway. This may allow the company to get through until the company or its partners generate some news that could lift the share price. I would question the company if there is a financing of any size below 20¢.
I am not spending time on Bioasis as Finallytherock alleges. I do not read scientific papers anymore. I follow a couple of pharma and biotech news sources but that's ten or fifteen minutes of work per day. I get a lot of news from automated searches. I'll report here or somewhere else anything that shareholders ought to know.
What I am spending time on is my new project that is completely unrelated to the stock market and science/medicine. And I'm spending time on some legal things relating to new and previous activities.
jd